| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.05. | VVT Med Provides Update on Management Cease Trade Order | 2 | CNW | ||
| 27.05. | VVT Med Inc: VVT Med sees first patients treated with ScleroSafe | 1 | Stockwatch | ||
| 16.05. | VVT Med Inc: VVT Med has no material changes | 1 | Stockwatch | ||
| 15.05. | VVT Med Provides Update on Management Cease Trade Order | 1 | CNW | ||
| 02.05. | VVT Med Inc: VVT Med receives management cease trade order | 3 | Stockwatch | ||
| 02.05. | VVT Med Announces Receipt of Management Cease Trade Order | 2 | CNW | ||
| 01.05. | VVT Med Inc: VVT Med talks clinical success of ScleroSafe study | 2 | Stockwatch | ||
| 30.04. | VVT Med Inc.: VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery | 1 | GlobeNewswire (USA) | ||
| VVT MED Aktie jetzt für 0€ handeln | |||||
| 27.04. | VVT Med Inc.: VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor | 1 | GlobeNewswire (USA) | ||
| 23.04. | VVT Med Inc: VVT Med closes $1.06-million first tranche of financing | 2 | Stockwatch | ||
| 22.04. | VVT Med Closes $1,065,664 First Tranche of Private Placement of Units | 2 | CNW | ||
| 22.04. | VVT Med Inc: VVT Med 1,203,410 shares for debt | 2 | Stockwatch | ||
| 17.04. | VVT Med Inc: VVT Med applies for management cease trade order | 1 | Stockwatch | ||
| 17.04. | VVT Med Announces Application for Management Cease Trade Order | 2 | CNW | ||
| 18.03. | VVT Med Announces Private Placement of Units | 1 | CNW | ||
| 26.11.25 | Toronto Stock Exchange: VVT Medical Inc. (VVTM) Opens the Market | 363 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Erez Tetro, Chief Executive Officer, VVT Medical Inc. ("VVT", "VVT Medical", or the "Company") (TSXV: VVTM) and his team, joined Dani Lipkin... ► Artikel lesen | |
| 23.07.25 | VVT Med Inc. (Formerly DXI Capital Corp.) Completes Reverse Takeover of V.V.T. Med Ltd. and Exiteam Acquisition Corp | 839 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - VVT Med Inc. (TSXV: DXI.H) (formerly DXI Capital Corp.) (the "Company") is pleased to announce that it has completed its previously announced acquisition... ► Artikel lesen | |
| 16.07.25 | DXI Capital Corp. Effects Share Consolidation and Name Change in Advance of Closing Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 430 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - Further to the transaction update provided in its press release dated June 30, 2025, DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to announce... ► Artikel lesen | |
| 01.07.25 | DXI Capital Corp. Provides Update on the Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 723 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to provide an update on its proposed acquisition of V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,920 | 0,00 % | Fresenius Aktie: JPMorgan bestätigt Empfehlung - CEO stockt auf | Die US-Bank JPMorgan sieht bei Fresenius weiterhin deutliches Aufwärtspotenzial und beließ die Aktie mit einem Kursziel von 56,60 Euro auf "Overweight". Zusätzlich steht der Titel auf der hauseigenen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,370 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| UNITEDHEALTH | 351,40 | -0,40 % | Analysten bullish: BofA stuft hoch - UnitedHealth-Aktie vor neuer Rallye? | © Foto: SOPA Images - Sipa USADer Umbau bei UnitedHealth zahlt sich offenbar aus und lässt die Bank of America auf weitere starke Kursgewinne hoffen.Die UnitedHealth Group könnte laut einer neuen Einschätzung... ► Artikel lesen | |
| DRAEGERWERK | 89,90 | 0,00 % | JEFFERIES stuft Draegerwerk auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Drägerwerk von 73 auf 90 Euro angehoben, aber die Einstufung auf "Hold" belassen. Die Margenentwicklung des Spezialisten... ► Artikel lesen | |
| INNOVAQOR | - | - | InnovaQor, Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| BOSTON SCIENTIFIC | 42,425 | +0,41 % | Boston Scientific to open $138M medical device distribution facility in Indiana, adding 300 jobs | ||
| PLUS THERAPEUTICS | 4,600 | 0,00 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| SPINEWAY | 0,129 | 0,00 % | Spineway: First-quarter 2026 revenue | Ecully, April 30, 2026 - 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,22 | 0,00 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| PROGYNY | 25,920 | 0,00 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| FRESENIUS MEDICAL CARE | 37,960 | 0,00 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,350 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,345 | -0,03 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| BILLIONTOONE | 94,32 | -0,12 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen |